# OnCo record histopathology-ihc (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/histopathology-ihc/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "histopathology-ihc" ;
  schema:name "Histopathology & immunohistochemistry"@en ;
  schema:description "Histopathology means looking at cancer cells under a microscope, and immunohistochemistry stains them for specific proteins. Together they are still the foundation of every diagnosis."@en ;
  schema:url <https://onco.cc/technologies/histopathology-ihc/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Immunohistochemistry> ;
  owl:sameAs <http://www.wikidata.org/entity/Q899285> ;
  schema:citation <https://en.wikipedia.org/wiki/Immunohistochemistry>, <https://doi.org/10.1182/blood-2003-05-1545>, <https://doi.org/10.1038/nrc2542> ;
  onco:status "standard-of-care" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:companies <https://onco.cc/companies/cyted-health/>, <https://onco.cc/companies/digistain/>, <https://onco.cc/companies/histowiz/>, <https://onco.cc/companies/ibex-medical-analytics/> ;
  onco:terms <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/her2-low/>, <https://onco.cc/terms/tils/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-valtorta-her2-scoring-colorectal-heracles-mod-pathol-2015/>, <https://onco.cc/key-papers/paper-pages-immunoscore-international-validation-lancet-2018/>, <https://onco.cc/key-papers/paper-moreira-lynch-syndrome-identification-jama-2012/>, <https://onco.cc/key-papers/paper-blueprint-phase-2-pd-l1-assays-jto-2018/>, <https://onco.cc/key-papers/paper-rimm-pd-l1-assay-comparison-jama-oncol-2017/>, <https://onco.cc/key-papers/paper-baine-sclc-subtype-immunohistochemistry-jto-2020/>, <https://onco.cc/key-papers/paper-lindeman-lung-molecular-testing-guideline-jto-2018/> ;
  onco:journals <https://onco.cc/journals/analytical-cellular-pathology/>, <https://onco.cc/journals/cancer-cytopathology/>, <https://onco.cc/journals/head-and-neck-pathology/>, <https://onco.cc/journals/pathology-and-oncology-research/> .